Table 5.
Drug interaction | Dimethyl fumaratea | Fingolimod | Teriflunomide |
Antineoplastic, immunosuppressive, or immunomodulating therapies | X | ||
CYP1A2 substrates (eg, duloxetine, alosetron, theophylline, tizanidine) | X | ||
CYP2C8 substrates (eg, repaglinide, paclitaxel, pioglitazone, rosiglitazone) | X | ||
Drugs that slow heart rate or atrioventricular conduction (eg, beta-blockers, diltiazem) | X | ||
Ketoconazole | X | ||
Oral contraceptives | X | ||
QT-prolonging drugs (eg, citalopram, chlorpromazine, haloperidol, methadone, erythromycin) | X | ||
Vaccines | X | X | |
Warfarin | X |
None reported in the product labeling for dimethyl fumarate.